◄ back to all posts

ELAN: Elanco Animal Health Inc Stock

Written by | Jul 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 15,183.17
Enterprise Value ($M) 21,434.17
Book Value ($M) 8,007.00
Book Value / Share 16.94
Price / Book n/a
NCAV ($M) -5,637.00
NCAV / Share -11.92
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.04
Return on Assets (ROA) -0.06
Return on Equity (ROE) -0.10

Liquidity (mrq)
Quick Ratio 0.94
Current Ratio 1.64

Balance Sheet (mrq) ($M)
Current Assets 3,344.00
Assets 16,988.00
Liabilities 8,981.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue n/a
Operating Income n/a
Net Income -560.10
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted -1.27
Earnings Per Share Basic -1.27

Cash Flow Statement (mra) ($M)
Cash From Operations -41.00
Cash from Investing -4,779.20
Cash from Financing -4,779.20

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-16 13G/A Price T Rowe Associates Inc /md/ 8.80 24.60
02-12 13G Janus Henderson Group Plc 7.40
02-12 13G/A Primecap Management Co/ca/ 6.89 6.32
02-10 13G/A Vanguard Group Inc 8.84 22.46
02-05 13G BlackRock Inc. 6.10 22.88
02-03 13G/A Wellington Management Group Llp 3.99 -39.09
02-02 13G Aristotle Capital Management, LLC 5.34
12-15 13D/A Sachem Head Capital Management LP 5.90 0.00
12-03 13G/A Bayer Aktiengesellschaft 3.91 -74.71
2019-03-25 13G Integrated Core Strategies (us) Llc 0.10
2019-02-14 13G ELI LILLY & Co 80.20

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-03-01 10-K Annual Report – 10-K
2020-11-06 10-Q Quarterly Report – 10-Q
2020-07-30 10-Q Quarterly Report – 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2021-05-12 137,227 3,283,700 4.18
2021-05-11 290,653 5,340,100 5.44
2021-05-10 274,921 3,096,600 8.88
2021-05-07 243,329 5,605,100 4.34

(click for more detail)

(click for list of largest short owners)

Similar Companies
BMY – Bristol-Myers Squibb Co CTLT – Catalent Inc
EBS – Emergent Biosolutions Inc ELAT – Elanco Animal Health Incorporated 5.00% Tangible Equity Units
GSK – GlaxoSmithKline plc


Financial data and stock pages provided by
Fintel.io




2018/07/06
◄ back to all posts

401 K